BACKGROUND: Although most epidemiological studies do not support a role for alcohol in the aetiology of pancreatic cancer, an increased risk among heavy drinkers cannot be excluded. METHODS: In a retrospective cohort based on the Swedish Inpatient Register, we analysed the risk of pancreatic cancer among patients admitted to hospital for alcoholism (n=178 688), alcoholic chronic pancreatitis (n=3500), non-alcoholic chronic pancreatitis (n=4952), alcoholic liver cirrhosis (n=13 553), or non-alcoholic liver cirrhosis (n=7057) from 1965 to 1994. Follow up through to 1995 was accomplished by linkage to nationwide registers. Standardised incidence ratios (SIRs) express the relative risks by taking the general Swedish population as reference. To minimise the possible influence of selection bias, we excluded the first year observations. RESULTS: Alcoholics had only a modest 40% excess risk of pancreatic cancer (SIR 1.4, 95% confidence interval (CI) 1.2-1.5). Overrepresented smokers among alcoholics might confound a true SIR of unity among alcoholics to approximately 1.4. SIR among alcoholic chronic pancreatitis patients (2.2, 95% CI 0.9-4.5) was considerably lower than that among non-alcoholic chronic pancreatitis patients (8.7, 95% CI 6.8-10.9), and decreased with increasing duration of follow up in both groups, indicating that most of the excess might be explained by reversed causation from undiagnosed cancers. Among patients with alcoholic liver cirrhosis, the increased risk of pancreatic cancer was also moderate (SIR 1.9, 95% CI 1.3-2.8) while no significant excess risk was found among non-alcoholic liver cirrhosis patients (SIR 1.2, 95% CI 0.6-2.2). CONCLUSIONS: The excess risk for pancreatic cancer among alcoholics is small and could conceivably be attributed to confounding by smoking.
BACKGROUND: Although most epidemiological studies do not support a role for alcohol in the aetiology of pancreatic cancer, an increased risk among heavy drinkers cannot be excluded. METHODS: In a retrospective cohort based on the Swedish Inpatient Register, we analysed the risk of pancreatic cancer among patients admitted to hospital for alcoholism (n=178 688), alcoholic chronic pancreatitis (n=3500), non-alcoholic chronic pancreatitis (n=4952), alcoholic liver cirrhosis (n=13 553), or non-alcoholic liver cirrhosis (n=7057) from 1965 to 1994. Follow up through to 1995 was accomplished by linkage to nationwide registers. Standardised incidence ratios (SIRs) express the relative risks by taking the general Swedish population as reference. To minimise the possible influence of selection bias, we excluded the first year observations. RESULTS: Alcoholics had only a modest 40% excess risk of pancreatic cancer (SIR 1.4, 95% confidence interval (CI) 1.2-1.5). Overrepresented smokers among alcoholics might confound a true SIR of unity among alcoholics to approximately 1.4. SIR among alcoholic chronic pancreatitispatients (2.2, 95% CI 0.9-4.5) was considerably lower than that among non-alcoholic chronic pancreatitispatients (8.7, 95% CI 6.8-10.9), and decreased with increasing duration of follow up in both groups, indicating that most of the excess might be explained by reversed causation from undiagnosed cancers. Among patients with alcoholic liver cirrhosis, the increased risk of pancreatic cancer was also moderate (SIR 1.9, 95% CI 1.3-2.8) while no significant excess risk was found among non-alcoholic liver cirrhosispatients (SIR 1.2, 95% CI 0.6-2.2). CONCLUSIONS: The excess risk for pancreatic cancer among alcoholics is small and could conceivably be attributed to confounding by smoking.
Authors: G A Colditz; E Giovannucci; E B Rimm; M J Stampfer; B Rosner; F E Speizer; E Gordis; W C Willett Journal: Am J Clin Nutr Date: 1991-07 Impact factor: 7.045
Authors: B T Ji; W H Chow; Q Dai; J K McLaughlin; J Benichou; M C Hatch; Y T Gao; J F Fraumeni Journal: Cancer Causes Control Date: 1995-07 Impact factor: 2.506
Authors: H O Adami; J K McLaughlin; A W Hsing; A Wolk; A Ekbom; L Holmberg; I Persson Journal: Cancer Causes Control Date: 1992-09 Impact factor: 2.506
Authors: W Zheng; J K McLaughlin; G Gridley; E Bjelke; L M Schuman; D T Silverman; S Wacholder; H T Co-Chien; W J Blot; J F Fraumeni Journal: Cancer Causes Control Date: 1993-09 Impact factor: 2.506
Authors: A B Lowenfels; P Maisonneuve; G Cavallini; R W Ammann; P G Lankisch; J R Andersen; E P Dimagno; A Andrén-Sandberg; L Domellöf Journal: N Engl J Med Date: 1993-05-20 Impact factor: 91.245
Authors: D T Silverman; L M Brown; R N Hoover; M Schiffman; K D Lillemoe; J B Schoenberg; G M Swanson; R B Hayes; R S Greenberg; J Benichou Journal: Cancer Res Date: 1995-11-01 Impact factor: 12.701
Authors: O Nyrén; J K McLaughlin; G Gridley; A Ekbom; O Johnell; J F Fraumeni; H O Adami Journal: J Natl Cancer Inst Date: 1995-01-04 Impact factor: 13.506
Authors: Dominique S Michaud; Alina Vrieling; Li Jiao; Julie B Mendelsohn; Emily Steplowski; Shannon M Lynch; Jean Wactawski-Wende; Alan A Arslan; H Bas Bueno-de-Mesquita; Charles S Fuchs; Myron Gross; Kathy Helzlsouer; Eric J Jacobs; Andrea Lacroix; Gloria Petersen; Wei Zheng; Naomi Allen; Laufey Ammundadottir; Manuela M Bergmann; Paolo Boffetta; Julie E Buring; Federico Canzian; Stephen J Chanock; Françoise Clavel-Chapelon; Sandra Clipp; Matthew S Freiberg; J Michael Gaziano; Edward L Giovannucci; Susan Hankinson; Patricia Hartge; Robert N Hoover; F Allan Hubbell; David J Hunter; Amy Hutchinson; Kevin Jacobs; Charles Kooperberg; Peter Kraft; Jonas Manjer; Carmen Navarro; Petra H M Peeters; Xiao-Ou Shu; Victoria Stevens; Gilles Thomas; Anne Tjønneland; Geoffrey S Tobias; Dimitrios Trichopoulos; Rosario Tumino; Paolo Vineis; Jarmo Virtamo; Robert Wallace; Brian M Wolpin; Kai Yu; Anne Zeleniuch-Jacquotte; Rachael Z Stolzenberg-Solomon Journal: Cancer Causes Control Date: 2010-04-07 Impact factor: 2.506
Authors: Yang Claire Yang; Moira P Johnson; Kristen M Schorpp; Courtney E Boen; Kathleen Mullan Harris Journal: Am J Prev Med Date: 2017-09 Impact factor: 5.043
Authors: Manal M Hassan; Melissa L Bondy; Robert A Wolff; James L Abbruzzese; Jean-Nicolas Vauthey; Peter W Pisters; Douglas B Evans; Rabia Khan; Ta-Hsu Chou; Renato Lenzi; Li Jiao; Donghui Li Journal: Am J Gastroenterol Date: 2007-08-31 Impact factor: 10.864
Authors: Marta Herreros-Villanueva; Elizabeth Hijona; Jesus Maria Bañales; Angel Cosme; Luis Bujanda Journal: World J Gastroenterol Date: 2013-02-07 Impact factor: 5.742
Authors: Jonas F Ludvigsson; Petra Otterblad-Olausson; Birgitta U Pettersson; Anders Ekbom Journal: Eur J Epidemiol Date: 2009-06-06 Impact factor: 8.082